STUDYING THE RELATIONSHIP BETWEEN BACTERIAL CONTAMINATION AND INFLAMMATION MARKERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE

1. Lin C.J., Chen H.H., Pan C.F., Chuang C.K., Wang T.J., Sun F.J. et al. P-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease. J. Clin. Lab. Anal- 2011, №25, 191-197.

2. Barreto F.C., Barreto D.V., Liabeuf S., Meert N., Glorieux G., Temmar M. et al. European UREMIC Toxin Work Group (EUTox). Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.Clin. J. Am. Soc. Nephrol. 2009 №4(10) Р.1551

3. Bammens B., Evenopoel P., Keuleers H., Verbeke K., Vanrenterghem Y. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int. 2006 №69(6) ,1081-1087.

4. Wang Z., Klipfell E., Bennett B.J., Koeth R., Levison B.S., Dugar B. et al. Gut fl ora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011 №472(7341), 57—63.

5. Aronov P.A., Luo F.J., Plummer N.S., Quan Z., Holmes S., Hostetter T.H. et al. Colonic contribution to uremic solutes J. Am. Soc. Nephrol. 2011 № 22(9) ,1769— 1776.

6. Vaziri N.D., Wong J., Pahl M., Piceno Y.M., Yuan J., DeSantis T.Z. et al. Chronic kidney disease alters intestinal microbial fl ora. Kidney Int. 2013 №83(2), 308—315.

7. Wu I.W., Hsu K.H., Lee C.C., Sun C.Y., Hsu H.J., Tsai C.J. et al. PCresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol. Dial. Transplant.2011 №26(3), 938—947.

8. Food and Agriculture Organization of the United Nations (FAO). Health and nutritional properties of probiotics in food including powder milk with live lactic acidbacteria. 2001 (Accessed 30 October 2013).

9. Krishnamurthy V.M., Wei G., Baird B.C., Murtaugh M., Chonchol M.B., Raphael K.L. et al. High dietary fi ber intake is associated with decreased infl ammation and all-cause mortality in patients with chronic kidney disease. Kidney Int. 2012 №-81(3), 300—306.

10.Delzenne N.M., Cani P.D., Daubioul C., Neyrinck A.M. Impact of inulin and oligofructose on gastrointestinal peptides. Br. J. Nutr. 2005-№93(Suppl.1), 157—161.

11.Delzenne N.M., Cani P.D., Daubioul C., Neyrinck A.M. Impact of inulin and oligofructose on gastrointestinal peptides. Br. J. Nutr. 2005 №93(Suppl.1) ,157—161.

12.Goraya N., Wesson D.E. Acid-base status and progression of Chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2012 №21(5), 552—556.

13.Konstantinov S.R., Smidt H., de Vos W.M., Bruijns S.C., Singh S.K., Valence F. et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc. Natl. Acad. Sci. U.S.A. 2008 №105(49), 19474—9.

14.Van Baarlen P., Troost F.J., van Hemert S., van der Meer C., de Vos W.M., de Groot P.J. et al. Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc. Natl. Acad. Sci. U.S.A. 2009 №106(7), 2371—6.

15.Hida M., Aiba Y., Sawamura S., Suzuki N., Satoh T., Koga Y. et al. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron.1996 №74(2), 349-355.